Hostname: page-component-848d4c4894-hfldf Total loading time: 0 Render date: 2024-05-16T23:24:26.794Z Has data issue: false hasContentIssue false
  • English
  • Français

Development of Subtype Selective GABAA Modulators

Published online by Cambridge University Press:  07 November 2014

Gerard R. Dawson ,
Neil Collinson  and
John R. Atack
Get access Rights & Permissions [Opens in a new window]

Abstract

Drugs modulating γ-aminobutyric acid (GABA) transmission via the benzodiazepine (BZ) site on the γ-aminobutyric acid type A (GABAA) receptor have been in widespread use for more than 40 years to treat anxiety, epilepsy, and sleep disorders. These drugs have been shown to be safe, well tolerated, and effective although the mechanism by they produce a myriad of pharmacologic effects remains elusive. In recent years it has been discovered that, although the GABAA receptor is widely distributed in the brain, the substructure and composition of the receptor differs from between brain regions. Termed “GABAA receptor subtypes” their discovery leads to speculation that different subtypes may mediate specific effects of BZs such as anxiety or sedation. The phenotypic analysis of transgenic knock-in and knock-out mice in which particular GABAA receptors were rendered insensitive to the effects of BZ while others were unaffected confirmed this speculation. Subsequently, subtype-specific GABAA ligands were developed that, for example, retained the anxiolytic effects of BZs but were devoid of their sedative effects. Therefore, it may be possible to develop effective anxiolytic compounds that have a much reduced side-effect profile compared with existing drugs.

Type
Review Article
Information
CNS Spectrums , Volume 10 , Issue 1 , January 2005 , pp. 21 - 27
Copyright
Copyright © Cambridge University Press 2005

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1. Sieghart, W. Structure and pharmacology of γ-aminobutyric acid A receptor subtypes. Pharmacol Rev. 1995;47:181–234.Google Scholar
2. Barnard, EA, Skolnick, P, Olsen, RW, et al. International Union of Pharmacology. XV. Subtypes of γ-aminobutyric acidA receptors: classification on the basis of subunit structure and function. Pharmacol Rev. 1998;50:291–313.Google Scholar
3. Bormann, J. The ‘ABC‘ of GABA receptors. Trends Pharmacol Sci. 2000;21:16–19.CrossRefGoogle ScholarPubMed
4. Smith, GB, Olsen, RW. Functional domains of GABAA receptors. Trends Pharmacol Sci. 1995;16:162–168.Google Scholar
5. Squires, RF, Braestrup, C. Benzodiazepine receptors in rat brain. Nature. 1977;266:732–734.Google Scholar
6. Sieghart, W, Drexler, G. Irreversible binding of [3H] flunitrazepam to different proteins in various brain regions. J Neurochem. 1983;41:47–55.Google Scholar
7. Sigel, E, Barnard, EA. A γ-aminobutyric acid/benzodiazepine receptor complex from bovine cerebral cortex. Improved purification with preservation of regulatory sites and their interactions. J Biol Chem. 1984;259:7219–7233.CrossRefGoogle ScholarPubMed
8. Whiting, PJ, McKernan, RM, Wafford, KA. Structure and pharmacology of vertebrate GABAA receptor subtypes. Int Rev Neurobiol. 1995;38:95–138.Google Scholar
9. Seeburg, PH, Wisden, W, Verdoom, TA, et al. The GABAA receptor family: molecular and functional diversity. Cold Spring Harb Symp Quant Biol. 1990;55:29–40.CrossRefGoogle ScholarPubMed
10. Sieghart, W, Fuchs, K, Tretter, V, et al. Structure and subunit composition of GABAA receptors. Neurochem Int. 1999;34:379–385.Google Scholar
11. Nayeem, N, Green, TP, Martin, IL, Barnard, EA. Quaternary structure of the native GABAA receptor determined by electron microscopic image analysis. J Neurochem. 1994;62:815–818.Google Scholar
12. Tretter, V, Ehya, N, Fuchs, K, Sieghart, W. Stoichiometry and assembly of a recombinant GABAA receptor subtype. J Neurosci. 1997;17:2728–2737.Google Scholar
13. Botmett, TP, McKernan, RM, Farrar, S, et al. a novel γ-aminobutyric acid type A receptor subunit. Proc Natl Acad Sci USA. 1999;96:9891–9896.Google Scholar
14. Pritchett, DB, Sontheimer, H, Shivers, BD, et al Importance of a novel GABAA receptor subunit for benzodiazepine pharmacology. Nature. 1989;338:582–585.Google Scholar
15. Sieghart, W, Sperk, G Subunit composition, distribution and function of GABAA receptor subtypes. Curr Top Med Chem. 2002;2:795–816.Google Scholar
16. McKernan, RM, Whiting, PJ. Which GABAA-receptor subtypes really occur in the brain? Trends Neurosci. 1996; 19:139–143.CrossRefGoogle ScholarPubMed
17. Jechlinger, M, Pelz, R, Tretter, V, Klausberger, T, Sieghart, W. Subunit composition and quantitative importance of hetero-oligomeric receptors: GABAA receptors containing α6 subunits. J Neurosci. 1998;18:2449–2457.CrossRefGoogle ScholarPubMed
18. Bencsits, E, Ebert, V, Tretter, V, Sieghart, W. A significant part of native γ-aminobutyric AcidA receptors containing α4 subunits do not containing γ or δ subunits. J Biol Chem. 1999;274:19613–19616.Google Scholar
19. Benke, D, Mertens, S, Trzeciak, A, Gillessen, D, Möhler, H. GABAA receptors display association of γ2-subunit with α1 - and ß2/3-subunits. J Biol Chem. 1991;266:4478–4483.Google Scholar
20. Duggan, MJ, Pollard, S, Stephenson, FA. Quantitative immunoprecipitation studies with anti-γ-aminobutyric acidA receptor γ2 1-15 Cys antibodies. J Neurochem. 1992;58:72–77.CrossRefGoogle Scholar
21. Ruano, D, Araujo, F, Machado, A, de Blas, AL, Vitorica, J. Molecular characterization of type I GABAA receptor complex from rat cerebral cortex and hippocampus. Mol Brain Res. 1994;25:225–233.Google Scholar
22. McKernan, RM, Quirk, K, Prince, R, et al. GABAA receptor subtypes immunopurified from rat brain with α subunit-specific antibodies have unique pharmacological properties. Neuron. 1991;7:667–676.CrossRefGoogle ScholarPubMed
23. Endo, S, Olsen, RW. Antibodies specific for α-subunit subtypes of GABAA receptors reveal brain regional heterogeneity. J Neurochem. 1993;60:1388–1398.CrossRefGoogle ScholarPubMed
24. Mertens, S, Benke, D Möhler, H. GABAA receptor populations with novel subunit combinations and drug binding profiles identified in brain by α5- and δ-subunit specific immunopurification. J Biol Chem. 1993;268:5965–5973.Google Scholar
25. Benke, D, Fritschy, JM, Trzeciak, A, Bannwarth, W, Möhler, H. Distribution, prevalence and drug-binding profile of GABAA receptor subtypes differing in ß-subunit isoform. J Biol Chem. 1994;269:27100–27107.Google Scholar
26. Quirk, K, Gillard, NP, Ragan, CI, Whiting, PJ, McKernan, RM. γ-aminobutyric acid type A receptors in rat brain can contain both γ2 and γ3 subunits, but γ1 does not exist in combination with another γ subunit. Mol Pharmacol. 1994;45:1061–1070.Google Scholar
27. Togel, M, Mossier, B, Fuchs, K, Sieghart, W. Γ-Aminobutyric acidA receptors displaying association of γ3-subunits with ß2/3 and different α-subunits exhibit unique pharmacological properties. J Biol Chem. 1994;269:12993–12998.Google Scholar
28. Fritschy, JM, Möhler, H. GABAA receptor heterogeneity in the adult rat brain: differential regional and cellular distribution of seven major subunits. J Comp Neurol. 1995;359:154–194.CrossRefGoogle ScholarPubMed
29. Ernst, M, Brauchart, D, Boresch, S, Sieghart, W. Comparative modeling of GABAA receptors: limits, insights, future developments. Neuroscience. 2003;119:933–943.CrossRefGoogle ScholarPubMed
30. Shivers, BD, Killisch, I, Sprengel, R, et al. Two novel GABAA receptor subunits exist in distinct neuronal subpopulations. Neuron. 1989;3:327–337.Google Scholar
31. Davies, PA, Hanna, MC, Hales, TG, Kirkness, EF. Insensitivity to anaesthetic agents conferred by a class of GABAA receptor subunit. Nature. 1997;385:820–823.Google Scholar
32. Hedblom, E, Kirkness, EF. A novel class of GABAA receptor subunit in tissues of the reproductive system. J Biol Chem. 1997;272:15346–15350.Google Scholar
33. Whiting, PJ, McAllister, G, Vassilatis, D, et al. Neuronally restricted RNA splicing regulates the expression of a novel GABAA receptor subunit conferring atypical functional properties. J Neurosci. 1997;17:5027–5037.Google Scholar
34. Whiting, PJ. The GABAA receptor gene family: new targets for therapeutic intervention. Neurochem Int. 1999;34:387–390.CrossRefGoogle ScholarPubMed
35. Enz, R, Cutting, GR. Molecular composition of GABAC receptors. Vision Res, 1998;38:1431–1441.Google Scholar
36. Cromer, BA, Morton, CJ, Parker, MW. Anxiety over GABAA receptor structure relieved by AChBP. Trends Biochem Sci. 2002;27:280–287.Google Scholar
37. Brejc, K, van Dijk, WJ, Klaassen, RV, et al. Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors. Nature. 2001;411:269–276.Google Scholar
38. Minier, F, Sigel, E. Positioning of the alpha-subunit isoforms confers a functional signature to gamma-aminobutyric acid type A receptors. Proc Natl Acad Sci USA. 2004;101:7769–7774.Google Scholar
39. Minier, F, Sigel, E. Techniques: use of concatenated subunits for the study of ligandgated ion channels. Trends Pharmacol Sci. 2004;5:499–503.CrossRefGoogle Scholar
40. Wisden, W, Laurie, DJ, Monyer, HM, Seeburg, PH. The distribution of thirteen GABAA receptor subunit mRNAs in the rat brain. I. Telencephalon, diencephalon and mesencephalon. J Neurosci. 1992;12:1040–1062.Google Scholar
41. Pirker, S, Schwarzer, C, Wieselthaler, A, Sieghart, W, Sperk, G. GABA(A) receptors: immunocytochemical distribution of 13 subunits in the adult rat brain. Neuroscience. 2000;101:815–850.Google Scholar
42. Pritchett, DB, Lüddens, H, Seeburg, PH. Type I and type II GABAA-benzodiazepine receptors produced in transfected cells. Science. 1989;245:1389–1392.Google Scholar
II benzodiazepine receptor pharmacology. J Neurochem. 1990;54:1802–1804.Google Scholar
44. Faure-Halley, C, Graham, D, Arbilla, S, Langer, SZ. Expression and properties of recombinant alpha 1 beta 2 gamma 2 and alpha 5 beta 2 gamma 2 forms of the rat GABAA receptor. Eur J Pharmacol. 1993;246:283–287.Google Scholar
45. Skolnick, P, Hu, RJ, Cook, CM, et al. [3H]RY 80: a high-affinity, selective ligand for γ-aminobutyric acidA receptors containing α5 subunits. J Pharmacol Exp Therap. 1997;283:488–493.Google Scholar
46. Sur, C, Fresu, L, Howell, O, McKernan, RM, Atack, JR. Autoradiographic localization of α5 subunit-containing GABAA receptors in rat brain. Brain Res. 1999;822:265–270.Google Scholar
47. Rosahl, TW. Validation of GABA receptor subtypes as potential drug targets by using genetically modified mice. Curr Drug Targets CNS Neurol Disord. 2003;2:53–59.Google Scholar
48. Rudolph, U, Möhler, H. Analysis of GABAA receptor function and dissection of the pharmacology of benzodiazepines and general anesthetics through mouse genetics. Annu Rev Pharmacol Toxicol. 2004;44:475–498.Google Scholar
49. Woods, JH, Katz, JL, Winger, G. Benzodiazepines: use, abuse, and consequences. Pharmacol Rev. 1992;44:151–347.Google Scholar
50. Hollister, LE, Muller-Oerlinghausen, B, Rickels, K, Shader, RI. Clinical uses of benzodiazepines. J Clin Psychopharmacol. 1993;1S–169S.Google Scholar
51. Costa, E, Guidotti, A, Mao, CC, Suria, A. New concepts on the mechanism of action of benzodiazepines. Life Sci. 1975;17:167–185.Google Scholar
52. Haefely, W, Kulcsar, A, Möhler, H, Pieri, L, Polc, P, Schaffner, R. Possible involvement of GABA in the central actions of benzodiazepines. Adv Blochem Psychopharmacol. 1975;14:131–151.Google Scholar
53. Möhler, H, Okada, T. Benzodiazepine receptor: demonstration in the central nervous system. Science. 1977;198:849–851.Google Scholar
54. Hunkeler, W, Möhler, H, Pieri, L, et al. Selective antagonists of benzodiazepines. Nature. 1981;290:514–516.Google Scholar
55. Cowen, PJ, Green, AR, Nutt, DJ, Martin, IP. Ethyl beta-carboline carboxylate lowers seizure threshold and antagonizes flurazepam-induced sedation in rats. Nature 1981;290:54–55.Google Scholar
56. Luddens, H, Pritchett, DB, Kohler, M, et al. Cerebellar GABAA receptor selective for a behavioural alcohol antagonist. Nature. 1990;346:648–651.CrossRefGoogle ScholarPubMed
57. Wisden, W, Herb, A, Wieland, H. Cloning, pharmacological characteristics and expression pattern of rat GABAA receptor γ4 subunit. FEBS Lett. 1991;289:227–230.Google Scholar
58. Wieland, HA, Luddens, H, Seeburg, PH. A single histidine in GABAA receptors is essential for benzodiazepine agonist binding. J Biol Chem. 1992;267:1426–1429.Google Scholar
59. Kleingoor, C, Wieland, HA, Korpi, ER, Seeburg, PH, Kettenmann, H. Current potentiation by diazepam but not GABA sensitivity is determined by a single histidine residue. Neuroreport. 1993;2:187–190.CrossRefGoogle Scholar
60. Rudolph, U, Crestani, F, Brunig, I, et al. Benzodiazepine actions mediated by specific -aminobutyric acidA receptor subtypes. Nature. 1999;401:796–800.Google Scholar
61. McKernan, RM, Rosahl, TW, Reynolds, DS, et al. Sedative but not anxiolytic properties of benzodiazepines are mediared by the GABAA receptor α1 subtype. Nat Neurosci. 2000;3:587–592.Google Scholar
62. Low, K, Crestani, F, Keist, R, et al. Molecular and neuronal substrate for the selective attenuation of anxiety. Science. 2000;290:131–134.Google Scholar
63. Squires, RF, Benson, DI, Braestrup, C, Coupet, J, Myers, V, Beer, B. Some properties of brain specific benzodiazepine receptor: new evidence for multiple receptors. Pharmacol Biochem Behav. 1979;10:825–830.Google Scholar
64. Arbilla, S, Allen, J, Wick, A, Langer, SZ High affinity [3H]zolpidem binding in the rat brain: an Imidazopyridine with agonist properties at central benzodiazepine receptors. Eur J Pharmacol. 1986;130:257–263.Google Scholar
65. Li, X, Cao, H, Zhang, C, et al. Synthesis, in vitro affinity, and efficacy of a bis 8-ethynyl-4H-imidazo[1,5a]-[1,4]benzodiazepine analogue, the first bivalent α5 subtype selective BzR/GABAA antagonist. J Med Chem. 2003;46:5567–5570.Google Scholar
66. Rush, CR. Behavioral pharmacology of Zolpidem relative to benzodiazepines: a review. Pharmacol Biochem Behav. 1998;61:253–269.Google Scholar
67. Bayley, PJ, Bentley, GD, Jackson, AJ, Williamson, D, Dawson, GR. Comparison of benzodiazepine (BZ) receptor agonists in two rodent activity tests. J Psychopharmacol. 1996;10:206–213.Google Scholar
68. Rowlett, JK, Cook, JM, Duke, AN, Platt, DM. Selective antagonism of GABAA receptor subtypes: an in vivo approach to exploring the therapeutic and side effects of benzodiazepine-type drugs. CNS Spectr. 2005;10:40–48.Google Scholar
69. Collinson, N, Kuenzi, FM, Jarolimek, W, et al. Enhanced learning and memory and altered GABAergic synaptic transmission in mice lacking the α5 subunit of the GABAA receptor. J Neurosci. 2002;22:5572–5580.Google Scholar
70. Crestani, F, Keist, R, Fritschy, JM, et al. Trace fear conditioning involves hippocampal alpha5 GABA(A) receptots. Proc Natl Acad Sci USA. 2002; 9:8980–8985.Google Scholar
71. Maubach, K. GABAA receptor subtype selective cognition enhancers. Curr Drug Targets CNS Neurol Disord. 2003;2:233–239 Google Scholar
72. Sternfeld, F, Carling, RW, Jelley, RA, et al. Selective, orally active γ-aminobutyric acidA α5 receptor inverse agonists as cognition enhancers. J Med Chem. 2004;47:2176–2179.Google Scholar